Table 5A.
Parameter | Beta Estimate (Std Err) | 95% CI | P-value |
---|---|---|---|
Intercept | −35.14 (11.74) | −59.80, −10.48 | 0.0078 |
Active–Sham Sequence (vs Sham–Active Sequence) | 5.22 (13.12) | −22.74, 33.18 | 0.6962 |
Active Treatment (vs Sham Treatment) | −29.76 (10.92) | −53.04, −6.48 | 0.0078 |
Week 2 (vs Week 3) | 20.73 (10.92) | −2.56, 44.01 | 0.0772 |
All Randomized Patients Non-Missing Data at Particular Visit.
Summary of Parameter (Beta) Estimates from Mixed Model.
[1] A mixed model for percent change in mean OCS assessed prior to treatment each week that includes treatment, treatment sequence, and week as fixed effects and a subject level random effect was constructed.
[2] Active Treatment (vs Sham Treatment) is a one-sided p value.